A Pilot Study of SurVaxM in Children Progressive or Relapsed Medulloblastoma, High Grade Glioma, Ependymoma and Newly Diagnosed Diffuse Intrinsic Pontine Glioma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Ependymoma
Related studies linked through entity extraction aliases.
HER2-specific Chimeric Antigen Receptor (CAR) T Cells for Children With Ependymoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Study of Bempegaldesleukin (BEMPEG: NKTR-214) in Combination With Nivolumab in Children, Adolescents and Young Adults With Recurrent or Treatment-resistant Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Brain Tumor-Specific Immune Cells (IL13Ralpha2-CAR T Cells) for the Treatment of Leptomeningeal Glioblastoma, Ependymoma, or Medulloblastoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Proton Therapy Research Infrastructure- ProTRAIT- Neuro-oncology
- Status
- RECRUITING
- Phase
- N/A
Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms
- Status
- RECRUITING
- Phase
- PHASE1
Study of the Effect of GM-CSF on Macrophages in Ependymoma
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Innovative Trial for Understanding the Impact of Targeted Therapies in NF2-Related Schwannomatosis (INTUITT-NF2)
- Status
- RECRUITING
- Phase
- PHASE2
Study of B7-H3-Specific CAR T Cell Locoregional Immunotherapy for Diffuse Intrinsic Pontine Glioma/Diffuse Midline Glioma and Recurrent or Refractory Pediatric Central Nervous System Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Pediatric Trial of Indoximod With Chemotherapy and Radiation for Relapsed Brain Tumors or Newly Diagnosed DIPG
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
StrataXRT in Preventing Radiation Dermatitis in Pediatric Patients Undergoing Radiation Therapy to the Brain or Spinal Cord
- Status
- WITHDRAWN
- Phase
- PHASE1
Social Determinants of Health in Glioblastoma Population
- Status
- COMPLETED
- Phase
- N/A
LET Optimized IMPT in Treating Pediatric Patients With Ependymoma
- Status
- RECRUITING
- Phase
- PHASE1
Marizomib for Recurrent Low-Grade and Anaplastic Supratentorial, Infratentorial, and Spinal Cord Ependymoma
- Status
- TERMINATED
- Phase
- PHASE2
EGFR806-specific CAR T Cell Locoregional Immunotherapy for EGFR-positive Recurrent or Refractory Pediatric CNS Tumors
- Status
- COMPLETED
- Phase
- PHASE1
HER2-specific CAR T Cell Locoregional Immunotherapy for HER2-positive Recurrent/Refractory Pediatric CNS Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
SJDAWN: St. Jude Children's Research Hospital Phase 1 Study Evaluating Molecularly-Driven Doublet Therapies for Children and Young Adults With Recurrent Brain Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Rare CNS Tumors Outcomes &Risk
- Status
- COMPLETED
- Phase
- N/A
Vemurafenib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With BRAF V600 Mutations (A Pediatric MATCH Treatment Trial)
- Status
- COMPLETED
- Phase
- PHASE2
Memantine for Prevention of Cognitive Late Effects in Pediatric Patients Receiving Cranial Radiation Therapy for Localized Brain Tumors
- Status
- COMPLETED
- Phase
- PHASE2